VCP and cancer: Over the last decade, genetic and biochemical investigations have revealed the ATPase associated with various cellular activities (AAA+) chaperone p97, also called valosin containing protein (VCP) and Cdc48, as a potential therapeutic target for cancer [1,2,3,4,5,6].